Lucentis (Ranibizumab): Clinical Trials

1 trial of Lucentis (Ranibizumab), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Lucentis (Ranibizumab): new trials by email Literature Review of Lucentis (Ranibizumab) trials Research Report on Lucentis (Ranibizumab)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)
Lucentis (Ranibizumab) - Neovascular Age-Related Macular Degeneration
Phase 2CompletedUniversity of Miami402004-08-012006-06-26

Conditions studied

Fanconi Anemia, Complementation Group B (1)  ·  Macular Degeneration (1)  ·  Neovascularization, Pathologic (1)

Sponsors

University of Miami (1)

Countries

United States (1)

Top investigators

Philip J Rosenfeld, MD, PhD (1)

Results publications

PMID 19376495